Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−71.87 MXN
−4.42 B MXN
0.00 MXN
48.64 M
About Kodiak Sciences Inc
Sector
Industry
CEO
Victor Perlroth
Website
Headquarters
Palo Alto
Founded
2009
FIGI
BBG00X9DMRT4
Kodiak Sciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of therapeutics for retinal diseases. Its product pipeline includes KSI-301 for wet AMD, KSI-301 for diabetic eye disease, KSI-501 for DME and uveitis, KSI-201 for resistant wet AMD, and KSI-401 for dry AMD. The company was founded by Stephen A. Charles and Victor Perlroth in 2009 and is headquartered in Palo Alto, CA.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of KOD is 110.00 MXN — it hasn't changed in the past 24 hours. Watch KODIAK SCIENCES INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BMV exchange KODIAK SCIENCES INC stocks are traded under the ticker KOD.
KOD stock has fallen by −31.58% compared to the previous week, the month change is a −31.58% fall, over the last year KODIAK SCIENCES INC has showed a −31.58% decrease.
We've gathered analysts' opinions on KODIAK SCIENCES INC future price: according to them, KOD price has a max estimate of 124.01 MXN and a min estimate of 41.34 MXN. Watch KOD chart and read a more detailed KODIAK SCIENCES INC stock forecast: see what analysts think of KODIAK SCIENCES INC and suggest that you do with its stocks.
KOD stock is 0.00% volatile and has beta coefficient of 2.78. Track KODIAK SCIENCES INC stock price on the chart and check out the list of the most volatile stocks — is KODIAK SCIENCES INC there?
Today KODIAK SCIENCES INC has the market capitalization of 7.10 B, it has increased by 0.47% over the last week.
Yes, you can track KODIAK SCIENCES INC financials in yearly and quarterly reports right on TradingView.
KODIAK SCIENCES INC is going to release the next earnings report on Mar 27, 2025. Keep track of upcoming events with our Earnings Calendar.
KOD earnings for the last quarter are −16.55 MXN per share, whereas the estimation was −17.82 MXN resulting in a 7.14% surprise. The estimated earnings for the next quarter are −18.21 MXN per share. See more details about KODIAK SCIENCES INC earnings.
KODIAK SCIENCES INC revenue for the last quarter amounts to 0.00 MXN, matching the estimated figure, and no changes in revenue are expected for the next quarter.
KOD net income for the last quarter is −865.90 M MXN, while the quarter before that showed −827.53 M MXN of net income which accounts for −4.64% change. Track more KODIAK SCIENCES INC financial stats to get the full picture.
No, KOD doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 28, 2024, the company has 111.00 employees. See our rating of the largest employees — is KODIAK SCIENCES INC on this list?
Like other stocks, KOD shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade KODIAK SCIENCES INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So KODIAK SCIENCES INC technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating KODIAK SCIENCES INC stock shows the sell signal. See more of KODIAK SCIENCES INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.